Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

DeepMatter secures contracts with five new customers

Fri, 16th Oct 2020 10:14

(Sharecast News) - Digital chemistry technology company DeepMatter has secured contracts with five new major customers in the last two months, it announced on Friday, for its computer-aided synthesis design tool 'ICSYNTH'.
The AIM-traded firm said that in total, ICSYNTH customer numbers had more than doubled through the course of 2020, as it achieved 100% customer renewals, adding to its underlying revenue base.

It said the new customers included "some of the world's leading" multinational pharmaceutical, agrisciences, biotechnology and contract research organisations.

Retrosynthesis was a growing area of the life sciences research and development space, providing an increasing opportunity for ICSYNTH, the board said.

It described ICSYNTH as a "powerful computer-aided synthesis design tool" that enabled chemists to generate synthetic pathways for a target molecule, leading to better, faster and more cost-effective synthesis predictions.

ICSYNTH facilitated innovation by stimulating ideas for alternative or novel synthetic routes that otherwise might not be considered by the chemist, the company claimed.

Development work had recently been completed on a new user interface for the tool, facilitating greater ease of use, with new algorithms introduced to filter out erroneous data from any data source, including proprietary data in electronic laboratory notebooks, which the board said would lead to improved synthesis predictions, resulting in better productivity and time management.

"We are delighted to be supplying our powerful retrosynthesis and forward planning tools to these leaders in their field, expanding our customer base not only in the pharmaceutical industry but also within the agrisciences and contract research organisation sectors," said chief executive officer Mark Warne.

"With machine learning and cloud technologies both powerful tools in the race to accelerated drug discovery, we see a growing opportunity for both our ICSYNTH and DigitalGlassware platforms and look to the future with confidence."

At 1008 BST, shares in DeepMatter were up 1.43% at 1.78p.

Related Shares

More News
5 Jan 2023 13:13

IN BRIEF: DeepMatter Group delists from London's AIM

DeepMatter Group PLC - Glasgow, Scotland-based digital chemistry data company - AIM listing cancelled with effect Thursday.

12 Dec 2022 15:43

UK shareholder meetings calendar - next 7 days

1 Dec 2022 14:54

DeepMatter proposes AIM share cancellation, launches fundraise

(Alliance News) - DeepMatter Group PLC said on Thursday it proposes a cancellation of its shares from AIM, while also raising funds in a share issue v...

24 Nov 2022 13:54

DeepMatter shares plunge as board proposes delisting

(Sharecast News) - DeepMatter Group said in an update on Thursday that it has been in discussions with its major shareholders and potential institutio...

24 Nov 2022 11:15

AIM WINNERS & LOSERS: UOG well disappoints; Arkle finds pegmatites

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.